LiVeritas Biosciences, Inc. Information

LiVeritas Biosciences is a scientific intelligence company building and commercializing a suite of Mass Spec AI Co-Scientists for biopharma drug candidate characterization. AI is enabling an unprecedented wave of increasingly complex drug candidates creating more molecules to characterize than traditional biopharma laboratories can efficiently process. LiVeritas automates this analytical bottleneck. LiVeritas AI Co-Scientists execute expert LC-MS protein-characterization workflows, transforming complex analytical data into trusted, traceable scientific intelligence while preserving human scientific oversight. Our first commercially available AI Co-Scientists are Sylvia™ for Sequence Variant Analysis and Petra™ for Peptide Mapping & PTM Analysis. LiVeritas is expanding this product suite across the major protein-characterization workflows, helping biopharma scientists reduce repetitive analytical tasks, increase scientific capacity, shorten cycle times, and make faster, higher-confidence, lower risk, data-first drug-development decisions. LiVeritas is built on years of real-world biopharma scientific execution. We are transforming accumulated analytical experience including validated workflows, scientific data, expert knowledge, and hands-on drug-development insight into scalable AI Co-Scientists. Amplifying Scientists. Scaling Scientific Excellence.